Edgestream Partners, L.P. Bristol Myers Squibb CO Transaction History

Edgestream Partners, L.P.

$2.05 Billion
Q2 2024

A detailed history of Edgestream Partners, L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Edgestream Partners, L.P. holds 16,770 shares of BMY stock, worth $891,996. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,770

Previous 110,608 84.84%

Holding current value

$891,996

Previous $6 Million 88.4%

% of portfolio

0.03%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$40.25 - $52.99 $3.78 Million - $4.97 Million	-93,838 Reduced 84.84%	16,770 $696,000
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $858,889 - $973,814	17,901 Added 19.31%	110,608 $6 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $1.73 Million - $2.06 Million	35,655 Added 62.5%	92,707 $4.76 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $834,194 - $932,759	14,410 Added 33.79%	57,052 $3.31 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $2.89 Million - $3.21 Million	-45,349 Reduced 51.54%	42,642 $2.73 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $5.46 Million - $6.19 Million	83,105 Added 1700.88%	87,991 $6.1 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $713,698 - $845,119	-10,422 Reduced 68.08%	4,886 $351,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $998 - $590,361	-7,683 Reduced 33.42%	15,308 $1.09 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $905,280 - $997,030	12,466 Added 118.44%	22,991 $1.77 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $307,953 - $369,263	-5,009 Reduced 32.25%	10,525 $769,000
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $8.84 Million - $10.3 Million	-164,908 Reduced 91.39%	15,534 $969,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $9.55 Million - $11.2 Million	161,321 Added 843.68%	180,442 $10.7 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $986,659 - $1.07 Million	15,937 Added 500.53%	19,121 $1.28 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $319,842 - $359,728	-5,390 Reduced 62.86%	3,184 $201,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $495,062 - $560,996	8,574 New	8,574 $532,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $302,620 - $439,778	-6,522 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $320,947 - $418,647	6,522 New	6,522 $419,000
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $1.74 Million - $2.06 Million	-40,716 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$44.62 - $49.34 $1.5 Million - $1.65 Million	-33,517 Reduced 45.15%	40,716 $1.85 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $3.35 Million - $3.99 Million	74,233 New	74,233 $3.54 Million
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $2.32 Million - $2.62 Million	-42,126 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $2.13 Million - $2.65 Million	42,126 New	42,126 $2.33 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Bristol Myers Squibb CO Transaction History